SAROJA Stock Overview
Saroja Pharma Industries India Limited trades in, exports, and supplies pharma active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents in India, the Asia Pacific, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Saroja Pharma Industries India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹46.45 |
| 52 Week High | ₹82.90 |
| 52 Week Low | ₹35.00 |
| Beta | 0 |
| 1 Month Change | 32.34% |
| 3 Month Change | -8.83% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| SAROJA | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 8.0% | 1.3% | 1.6% |
| 1Y | n/a | 60.1% | 45.1% |
Return vs Industry: Insufficient data to determine how SAROJA performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how SAROJA performed against the Indian Market.
Price Volatility
| SAROJA volatility | |
|---|---|
| SAROJA Average Weekly Movement | 10.5% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: SAROJA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SAROJA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 13 | Biju Nair | www.sarojapharma.com |
Saroja Pharma Industries India Limited trades in, exports, and supplies pharma active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents in India, the Asia Pacific, and Europe. The company’s specialty chemicals and its intermediates are used in various applications, including pharma, agro, chemicals, performance chemicals, resins, paint, food, adhesive, and various other industries. Its products are also used in human and veterinary medicines.
Saroja Pharma Industries India Limited Fundamentals Summary
| SAROJA fundamental statistics | |
|---|---|
| Market cap | ₹186.75m |
| Earnings (TTM) | ₹10.15m |
| Revenue (TTM) | ₹447.72m |
18.4x
P/E Ratio0.4x
P/S RatioIs SAROJA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SAROJA income statement (TTM) | |
|---|---|
| Revenue | ₹447.72m |
| Cost of Revenue | ₹399.66m |
| Gross Profit | ₹48.06m |
| Other Expenses | ₹37.91m |
| Earnings | ₹10.15m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.52 |
| Gross Margin | 10.73% |
| Net Profit Margin | 2.27% |
| Debt/Equity Ratio | 83.7% |
How did SAROJA perform over the long term?
See historical performance and comparison